Devlin Nancy J, Hartgers-Gubbels Elisabeth Sophia, Chambers Michael
Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Int J Gen Med. 2022 Oct 12;15:7773-7779. doi: 10.2147/IJGM.S390090. eCollection 2022.
How do we measure quality of life and utility of interventions? In this episode of the Value Insider podcast, host Mike Chambers speaks with Prof. Nancy Devlin about incorporating quality of life in value assessment. Prof. Devlin is professor of health economics at the University of Melbourne. Her past roles include Director of Research at the Office of Health Economics (OHE) London, Professor of Health Economics at City University of London, and she has been director of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR). She is the Chair of the Board of the EuroQol Research Foundation, the international research organization which has developed and maintains the EQ-5D patient-reported outcome (PRO) instrument. Prof Devlin explains the value of the patient voice and how it can be measured and taken into account when considering the value of healthcare interventions.
我们如何衡量生活质量和干预措施的效用？在本期《价值内幕》播客中，主持人迈克·钱伯斯与南希·德夫林教授探讨了将生活质量纳入价值评估的问题。德夫林教授是墨尔本大学的卫生经济学教授。她过去的职位包括伦敦卫生经济办公室（OHE）的研究主任、伦敦城市大学的卫生经济学教授，并且她曾担任国际药物经济学和成果研究协会（ISPOR）的主任。她是欧洲生活质量研究基金会董事会主席，该国际研究组织开发并维护了EQ - 5D患者报告结局（PRO）工具。德夫林教授解释了患者声音的价值，以及在考虑医疗保健干预措施的价值时如何衡量和考虑患者声音。
